Effects of indomethacin on the divisional morphogenesis and cytoskeleton-dependent processes of Tetrahymena.
Indomethacin (0.1 mM) causes significantly altered phospholipid synthesis in Tetrahymena and is able to influence the inositol phospholipid signalling system (9). In the present study the effects of indomethacin on the course of cell division, cyclin expression, the cortical microtubular system and on cytoskeleton-dependent processes (motility, phagocytosis) were investigated. As expected from its interference with the synthesis of phospholipids, indomethacin affected Tetrahymena in a number of ways: the structure of the cortical microtubular system became irregular; in many cells the stomatogenesis (development of new oral apparatus) and the development of the fission furrow was not accompanied by elongation of the macronucleus, which is a typical phenomenon of the normal course of mitosis: apparently indomethacin uncouples these phenomena. After indomethacin treatment, the expression of both cyclin A and cyclin B(1) were reduced significantly. The cell growth rate, motility and phagocytotic activity were all considerably reduced. There are probably additional mechanisms responsible for the effect of indomethacin on the systems that control divisional morphogenesis, for microtubule-dependent processes and for the connection between nuclear and cortical alterations during the cell cycle. Effects on protein phosphorylation/dephosphorylation, on cyclin expression and on microtubular functions are probably involved. These possibilities are discussed.
Kovács
Péter
P
Department of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary. kovpet@dgci.sote.hu
Pállinger
Eva
E
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D002455:Cell Division / Q000187:drug effects*; D003599:Cytoskeleton / Q000187:drug effects*; D007213:Indomethacin / Q000494:pharmacology*; D015398:Signal Transduction / Q000502:physiology; D013768:Tetrahymena / Q000187:drug effects*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007213:Indomethacin